Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Linong Ji

Showing results (421-430 of 588) with videos related to

Pageof 59
Sort By:
Diabetes Technology & Therapeutics|July 13, 2016
Genetic and Clinical Predictive Factors of Sulfonylurea Failure in Patients with Type 2 DiabetesQian Ren, Di Xiao, Xueyao Han, et al.
Medicine|September 1, 2023
Changes of health-related quality of life after initiating basal insulin treatment among people with type 2 diabetesPuhong Zhang, Yuqian Bao, Minyuan Chen, et al.
Med (New York, N.Y.)|March 24, 2026
Mazdutide 9 mg in Chinese adults with a body mass index ≥30 kg/m<sup>2</sup> but without diabetes: A phase 2 randomized controlled trialLinong Ji, Hongwei Jiang, Zhifeng Cheng, et al.
Journal of Diabetes|June 3, 2011
First insulinization with basal insulin in patients with Type 2 diabetes in a real-world setting in AsiaShih-Tzer Tsai, Faruque Pathan, Linong Ji, et al.
Diabetes Research and Clinical Practice|December 14, 2025
Utility of continuous glucose monitoring in people with type 2 diabetes on insulin-based regimens in clinical practice: A case series and expert opinionSoo Lim, Rimei Nishimura, Jothydev Kesavadev, et al.
Diabetes, Obesity & Metabolism|March 5, 2019
Safety and efficacy of ertugliflozin in Asian patients with type 2 diabetes mellitus inadequately controlled with metformin monotherapy: VERTIS AsiaLinong Ji, Yanmei Liu, Heng Miao, et al.
Diabetes, Obesity & Metabolism|January 17, 2020
Higher versus standard starting dose of insulin glargine 100 U/mL in overweight or obese Chinese patients with type 2 diabetes: Results of a multicentre, open-label, randomized controlled trial (BEYOND VII)Linong Ji, Hailong Wan, Binhong Wen, et al.
Endocrine Connections|February 5, 2021
Sex differences in the prevalence of obesity in 800,000 Chinese adults with type 2 diabetesFang Lv, Xiaoling Cai, Chu Lin, et al.
Journal of Diabetes Investigation|July 2, 2022
Prevalence of obstructive sleep apnea syndrome in hospitalized patients with type 2 diabetes in Beijing, ChinaShan Ding, Puhong Zhang, Li Wang, et al.
Lipids in Health and Disease|April 15, 2016
HDL in diabetic nephropathy has less effect in endothelial repairing than diabetes without complicationsYufeng Li, Mingming Zhao, Dan He, et al.
Pageof 59

Showing results (421-430 of 588) with videos related to

Sort By:
Pageof 59
Diabetes Technology & Therapeutics|July 13, 2016
Genetic and Clinical Predictive Factors of Sulfonylurea Failure in Patients with Type 2 DiabetesQian Ren, Di Xiao, Xueyao Han, et al.
Medicine|September 1, 2023
Changes of health-related quality of life after initiating basal insulin treatment among people with type 2 diabetesPuhong Zhang, Yuqian Bao, Minyuan Chen, et al.
Med (New York, N.Y.)|March 24, 2026
Mazdutide 9 mg in Chinese adults with a body mass index ≥30 kg/m<sup>2</sup> but without diabetes: A phase 2 randomized controlled trialLinong Ji, Hongwei Jiang, Zhifeng Cheng, et al.
Journal of Diabetes|June 3, 2011
First insulinization with basal insulin in patients with Type 2 diabetes in a real-world setting in AsiaShih-Tzer Tsai, Faruque Pathan, Linong Ji, et al.
Diabetes Research and Clinical Practice|December 14, 2025
Utility of continuous glucose monitoring in people with type 2 diabetes on insulin-based regimens in clinical practice: A case series and expert opinionSoo Lim, Rimei Nishimura, Jothydev Kesavadev, et al.
Diabetes, Obesity & Metabolism|March 5, 2019
Safety and efficacy of ertugliflozin in Asian patients with type 2 diabetes mellitus inadequately controlled with metformin monotherapy: VERTIS AsiaLinong Ji, Yanmei Liu, Heng Miao, et al.
Diabetes, Obesity & Metabolism|January 17, 2020
Higher versus standard starting dose of insulin glargine 100 U/mL in overweight or obese Chinese patients with type 2 diabetes: Results of a multicentre, open-label, randomized controlled trial (BEYOND VII)Linong Ji, Hailong Wan, Binhong Wen, et al.
Endocrine Connections|February 5, 2021
Sex differences in the prevalence of obesity in 800,000 Chinese adults with type 2 diabetesFang Lv, Xiaoling Cai, Chu Lin, et al.
Journal of Diabetes Investigation|July 2, 2022
Prevalence of obstructive sleep apnea syndrome in hospitalized patients with type 2 diabetes in Beijing, ChinaShan Ding, Puhong Zhang, Li Wang, et al.
Lipids in Health and Disease|April 15, 2016
HDL in diabetic nephropathy has less effect in endothelial repairing than diabetes without complicationsYufeng Li, Mingming Zhao, Dan He, et al.
Pageof 59